Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,700 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
mSystems, 2023Abnormal blood microbiota profiles are associated with inflammation and immune restoration in HIV/AIDS individuals
Guo X., Wang Z., Qu M. et al.
Olink Target 96
Open Forum Infectious Diseases, 2023Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
Schnittman S., Kolossváry M., Beck-Engeser G. et al.
BMC Medicine, 2023Integrated unbiased multiomics defines disease-independent placental clusters in common obstetrical syndromes
Barak O., Lovelace T., Piekos S. et al.
Translational Neurodegeneration, 2023Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
Paslawski W., Khosousi S., Hertz E. et al.
Clinical Immunology, 2023Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children
Amodio D., Pascucci G., Cotugno N. et al.
Journal of the American Heart Association, 2023Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
Xu Q., Sun L., Wang Y. et al.
Cell Reports Medicine, 2023Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses
Yuan S., Xu F., Li X. et al.
Olink Explore 3072/384
Vascular Pharmacology, 2023Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk
Edsfeldt A., Gonçalves I., Vigren I. et al.
Science Translational Medicine, 2023A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Van Damme K., Hoste L., Declercq J. et al.
Journal for ImmunoTherapy of Cancer, 2023Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
Anker J., Pal S., Kim-Schulze S. et al.
Liver International, 2023Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers
Stankevic E., Israelsen M., Juel H. et al.
Journal of Endocrinological Investigation, 2023Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture
Cedeno-Veloz B., Lozano-Vicario L., Rodríguez-García A. et al.
Olink Target 48
Nature Communications, 2023Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits
Brown A., Fernandez-Tajes J., Hong M. et al.
Journal of Cancer Research and Clinical Oncology, 2023Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study
Pham T., Nimptsch K., Papadimitriou N. et al.
Aging Cell, 2023Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort
Chen J., Doyle M., Fang Y. et al.
Journal of Cerebral Blood Flow & Metabolism, 2023A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease
Overmars L., Kuipers S., van Es B. et al.
iScience, 2023Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
Shivram H., Hackney J., Rosenberger C. et al.
Nature Immunology, 2023Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
Zhao J., Stacey D., Eriksson N. et al.
eClinicalMedicine, 2023Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study
Zinzani P., Trněný M., Ribrag V. et al.
Research and Practice in Thrombosis and Haemostasis, 2023Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach
Liu Z., McCutcheon F., Ho H. et al.
2798 publications
Items per page
1101-1120 of 2798 publications